AstraZeneca PLC is 53.3x more valuable than BELITE BIO, INC by market capitalization ($286.27 B vs $5.37 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BLTE | AZN |
|---|---|---|
| Market cap | $5.37 B | $286.27 B |
| US-listed rank | #1332 | #45 |
| Net income (latest FY) | -$77.61M | - |
| SEC filings | 194 | 1,004 |
AstraZeneca PLC is 53.3x more valuable than BELITE BIO, INC by market capitalization ($286.27 B vs $5.37 B).
Full pages: BELITE BIO, INC and AstraZeneca PLC, or browse the full rankings.